Featured
-
FDA Clears Darolutamide for Nonmetastatic Castration-Resistant Prostate Cancer
In the phase 3 ARAMIS trial, darolutamide, a nonsteroidal androgen receptor inhibitor, significantly delayed development of metastasis in men with nonmetastatic castration-resistant prostate cancer. -
SBRT Possibly Beneficial in Bone Oligometastatic Prostate Cancer
Men who underwent stereotactic body radiotherapy for hormone-sensitive bone-only oligometastatic prostate cancer had a median progression-free survival time of 24 months, a study found. -
CKD Ups Risk of Post-Op Complications After Radical Prostatectomy
Men with chronic kidney disease (CKD) at the time of radical prostatectomy are 5 times more likely to experience postoperative complications than those without CKD, a study found. -
Study: Start Dialysis Later in Children
Children initiating dialysis at higher eGFRs had a 36% higher risk for death than those initiating at lower eGFRs. -
Using Novel Anti-Androgens in Non-Metastatic CRPC
What should be the basis for starting non-metastatic CRPC patients on one of the novel anti-androgens? -
Roxadustat Effective in Correcting Anemia in Nondialysis CKD and Dialysis
In separate studies, roxadustat showed superiority over placebo at increasing hemoglobin in patients with CKD anemia and demonstrated noninferiority to epoetin in treating anemia in dialysis patients. -
Trump Outlines Bold Plan to Improve Kidney Disease Care
Initiatives include measures to boost kidney donations and encourage greater use of home dialysis and development of novel treatments. -
RCC in Advanced CKD: A Transplant Dilemma
Non-dialysis patients with advanced CKD diagnosed with renal malignancies grapple with the dual threat of renal failure and cancer progression. When choosing between functional or oncologic risks, many patients will ask about renal transplantation. Discussions of this option are complicated by statistical realities: According to UNOS, of nearly 1 million solid organ transplants performed over… -
Do You Really Have a Handle on Your PHI Data?
Health care organizations must determine where protective health information (PHI) is held and where those systems are vulnerable to breaches. -
How do you treat LGBTQ patients?
Clinicians should not feel uncomfortable asking questions about sexuality.
Latest Nephrology News
HbA1c, BMI Linked to Stillbirth Risk in Women With Diabetes
Urinary Marker Predicts AKI Following Cardiac Surgery
Children With Type 1 Diabetes Have Poorer Educational Outcomes
Latest Urology News
Facility Experience Impacts Survival Time After Prostate Surgery
UTUC With Isolated Lymph Node Involvement Predicts Poor Survival
